JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model.
暂无分享,去创建一个
Sandra A. Moore | S. Fröhling | T. Boggon | R. Levine | O. Bernard | D. Gilliland | T. Gu | Benjamin H. Lee | Dana E. Cullen | R. Polakiewicz | G. Wernig | T. Mercher